Not authorised any third party to supply Sputnik V, sole distributor in India: Dr Reddy’s


The Innovation Plaza building on the Dr Reddy’s Laboratories Ltd. campus in Hyderabad (representational image) | Prashanth Vishwanathan |
Bloomberg


Text Size:

New Delhi: Dr Reddy’s Laboratories has not authorised any third party to supply the Sputnik V COVID-19 vaccine on its behalf in India and has initiated legal action against unscrupulous elements committing fraud in the name of the Russian vaccine, a statement said.

“Dr Reddy’s Laboratories is the brand custodian of the Sputnik V vaccine in India and has the sole distribution rights of the first 250 million doses (first and second dose components included) of the vaccine in India,” the domestic pharma major and Russian Direct Investment Fund (RDIF) said in a joint statement.

In the last few days, there have been several unsubstantiated reports and claims from various quarters in India on alleged tie-ups for the Sputnik V vaccine, it added.

“We wish to clarify that Dr Reddy’s has not entered into any partnership or collaboration with any party to supply the Sputnik V vaccine to residential associations, nor has the company authorised any third party or intermediary to supply the vaccine on its behalf in India,” it added.

Cautioning people, the statement asked them to beware of unauthorised individuals offering fake deals or procurement of the Sputnik V vaccine posing as the firm’s representatives in India and asked them to alert the authorities immediately if approached.

“Dr Reddy’s has initiated legal action against unscrupulous elements committing fraud in the name of the Sputnik V vaccine in India. The company takes no responsibility for the consequences of unauthorised deals, fraudulent financial transactions or sub-standard products resulting from such fraud,” it added.

Dr Reddy’s has fully put in place cold storage logistics as well as track-and-trace arrangements for the vaccine.

These arrangements are absolutely imperative to ensure the safety and quality of the vaccine, and for pharmacovigilance, the statement said.

“Ahead of the commercial launch of the vaccine in mid-June, Dr Reddy’s continues to engage in direct talks with the Government and the private sector to explore partnerships,” the statement added.


Also read: Dr Reddy’s administers first dose of Sputnik V vaccine in India


 

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism